Edges in Network
| Network | GSE16391_top500tf - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | ALS2CR8 |
| Upstream (Parents) |
|---|
| (<<) ZNF396 → ALS2CR8 |
| (<<) TEAD2 → ALS2CR8 |
| (<<) MYBL2 → ALS2CR8 |
| (<<) ZNF192 → ALS2CR8 |
| (<<) ZNF45 → ALS2CR8 |
| (<<) LZTS1 → ALS2CR8 |
| (<<) KDM5A → ALS2CR8 |
| (<<) ZXDA → ALS2CR8 |
| Downstream (Children) |
|---|
| ALS2CR8 → IRX2 (>>) |
| ALS2CR8 → HLF (>>) |
| ALS2CR8 → LASS6 (>>) |
| ALS2CR8 → NANOG (>>) |
| ALS2CR8 → MMP14 (>>) |
| ALS2CR8 → CREBZF (>>) |
| ALS2CR8 → C5orf41 (>>) |
| ALS2CR8 → ENO1 (>>) |
| ALS2CR8 → SOX4 (>>) |
| ALS2CR8 → HMGA1 (>>) |
| ALS2CR8 → BCL3 (>>) |
| ALS2CR8 → ZNF287 (>>) |
| ALS2CR8 → ZNF397 (>>) |
| ALS2CR8 → ZNF236 (>>) |
| ALS2CR8 → FOXP4 (>>) |
| ALS2CR8 → VDR (>>) |
| ALS2CR8 → SPI1 (>>) |
| ALS2CR8 → PPARD (>>) |
| ALS2CR8 → MTF1 (>>) |
| ALS2CR8 → C1orf85 (>>) |
| ALS2CR8 → CREBL2 (>>) |
| ALS2CR8 → C2orf3 (>>) |
